跳至主要内容
临床试验/NCT06499714
NCT06499714已完成不适用

HighCycle Study: Effect of High Altitude on Acute Mountain Sickness in Women Related to Their Menstrual Cycle Phase: A Prospective Cohort Study at 3600 m

University of Zurich2 个研究点 分布在 1 个国家目标入组 91 人开始时间: 2024年7月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
91
试验地点
2
主要终点
Acute Mountain Sickness (AMS) Incidence, LLS 2018

研究概览

简要总结

Prospective cohort study investigating the menstrual cycle phase (MCP)-dependent incidence of acute mountain sickness (AMS) in women travelling to 3600 m.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 44 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy, non-smoking women, age 18-44 years, without any disease and need of regular medication (including oral contraceptives).
  • BMI >18 kg/m2 and <30 kg/m2
  • Born, raised and currently living at altitudes <1000 m
  • Written informed consent
  • Premenopausal, eumenorrheic cycle

排除标准

  • Other types of contraceptives (hormonal intrauterine device, vaginal ring, subcutaneous injections or implants, among others)
  • Pregnancy or nursing
  • Anaemic (haemoglobin concentration <10g/dl)
  • Any altitude trip <4 weks before the study
  • Allergy to acetazolamide and other sulfonamides

结局指标

主要结局

Acute Mountain Sickness (AMS) Incidence, LLS 2018

时间窗: Day 1 to 3 at 3600 m

MCP-related difference in the AMS incidence. AMS incidence will be defined as a Lake Louise Questionnaire version 2018 score of ≥3.

次要结局

  • Acute Mountain Sickness (AMS) Severity, LLS 1993(Day 1 to 3 at 3600 m)
  • Arterial blood gases(Day 2 at 760 m and day 2 at 3600 m)
  • Hypoxic ventilatory response(Day 2 at 760 m)
  • Perceived pain visualization(Day 1 to 3 at 3600 m)
  • Acute Mountain Sickness (AMS) Incidence, LLS 1993(Day 1 to 3 at 3600 m)
  • Acute Mountain Sickness (AMS) Severity, LLS 2018(Day 1 to 3 at 3600 m)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

HighCycle Study: Effect of High Altitude on Acute... | 临床试验